ALKS
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2021-01-01–present
Board Member
Alkermes plc. (ALKS)Equibles does not estimate personal net worth.
Get an email with a short summary when Alkermes plc. publishes a filing, an earnings call transcript or a press release.
Get ALKS alertsCato T. Laurencin is recorded as Board Member at Alkermes plc. (ALKS) since January 1, 2021. The newest filing on record that lists Cato T. Laurencin as Board Member at Alkermes plc. (ALKS) is dated April 6, 2026. Cato T. Laurencin was last confirmed as Board Member at Mimedx Group, Inc. (MDXG) in a filing dated April 30, 2025. Alkermes plc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Alkermes plc. includes Blair C. Jackson (CEO, CFO and COO), Mr. Richard F. Pops (CEO), Iain M. Brown (CFO and Chief Accounting Officer) and 7 others.
2021-01-01–present
Last confirmed April 6, 2026
2020-01-01–2025-04-30
Last confirmed by a filing; no departure on record
ALKS
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2021-01-01–present
MDXG
Biotechnology · Healthcare
Board Member
Since 2020-01-01, last confirmed 2025-04-30
No call appearances or filed executive changes recorded yet.